Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas

Published:2013-06-04 Issue:9 Volume:15 Page:1160-1172
ISSN:1523-5866
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Xu Shuo,Shao Qian-Qian,Sun Jin-Tang,Yang Ning,Xie Qi,Wang Dong-Hai,Huang Qi-Bing,Huang Bin,Wang Xin-Yu,Li Xin-Gang,Qu Xun

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/15/9/1160/16860129/not067.pdf

Reference53 articles.

1. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009;Dolecek;Neuro Oncol,2012

2. Malignant gliomas in adults;Wen;N Engl J Med,2008

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

4. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma;Van Meir;CA Cancer J Clin,2010

5. Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?;Heimberger;Neuro Oncol,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus;Journal of the Taiwan Institute of Chemical Engineers;2024-10

2. Mitochondria-related HSDL2 is a potential biomarker in temporal lobe epilepsy by modulating astrocytic lipid metabolism;Neurotherapeutics;2024-09

3. Tumor Metabolism: A New Field for the Treatment of Glioma;Bioconjugate Chemistry;2024-07-16

4. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19

5. Treatment advances in high-grade gliomas;Frontiers in Oncology;2024-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3